Reports On Company: Ajanta Pharma
| Ajanta Pharma is a focused player in branded generics. Buy for target price Rs 1950 (26% upside) | |
| Company: | Ajanta Pharma |
| Brokerage: | ICICI-Direct |
| Date of report: | August 28, 2023 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 26% |
| Summary: | Ajanta Pharma is a focused player in branded generics, which constitutes ~72% of overall sales, spread across geographies including India. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |
| Strong Buy Of Ajanta Pharma Ltd For 24% Upside | |
| Company: | Ajanta Pharma |
| Brokerage: | Stewart & Mackertich |
| Date of report: | March 4, 2020 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 24% |
| Summary: | Series of new product launch is driving growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |